ASF outbreak lifts Komipharm...Biodyne gains spotlight[K-Bio Pulse] 나은경 2026.02.05 오전 08:10 ABL Bio Slides on Sanofi Reprioritization...Stock Specific Risks Hit Biotechs[K-Bio Pulse] 김새미 2026.02.02 오전 08:10 '리보세라닙' FDA허가 표류 속 주가는 견고…HLB, 명과 암은? 김새미 2026.01.16 오전 08:30 Daehwa Pharmaceutical, Anygen Hit Upper Limit; HLB Group Stocks Struggle Amid Rumors[K-Bio Pulse] 김새미 2025.03.11 오전 08:10 계열사 50곳...M&A로 덩치불린 HLB의 목적지는 임정요 2025.02.25 오전 08:06 HLB Gains on Trial Data, NeoImmuneTech Sinks on CEO Exit[K-bio Pulse] 석지헌 2025.10.14 오전 07:59 HansBiomed Shares Surge on Explosive Growth of ECM Skin Booster[K-Bio Pulse] 신민준 2025.10.22 오전 08:07 HLB생명과학, 반려견 항암제 임상시험계획 승인 나은경 2022.03.23 오전 10:30 HLB와 계열사들, 학동역 웨딩홀 컨벤션헤리츠 1000억에 매입 임정요 2025.02.11 오후 03:28 Anigen·Daehwa·HLB. Strong Momentum[K-BIO Pulse] 김지완 2025.03.18 오전 08:18 더 보기 로딩중..
rivoceranib
rivoceranib
![ASF outbreak lifts Komipharm...Biodyne gains spotlight[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/02/PS26020500295b.jpg)
![ABL Bio Slides on Sanofi Reprioritization...Stock Specific Risks Hit Biotechs[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/02/PS26020200188b.jpg)
![Daehwa Pharmaceutical, Anygen Hit Upper Limit; HLB Group Stocks Struggle Amid Rumors[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031100284b.jpg)
![HLB Gains on Trial Data, NeoImmuneTech Sinks on CEO Exit[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/10/PS25101400159b.jpg)
![HansBiomed Shares Surge on Explosive Growth of ECM Skin Booster[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/10/PS25102200278b.jpg)
![Anigen·Daehwa·HLB. Strong Momentum[K-BIO Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031800287b.jpg)